One biomarker can make a difference.
Every year, promising cancer therapies are developed and approved, offering the potential for improved clinical outcomes for patients with qualifying cancer types. Comprehensive genomic profiling (CGP) can detect actionable variants to maximize the ability to match patients with appropriate molecular treatment regimens.
Accelerate precision medicine, maximize identification of molecularly matched therapies.
Download the eBook now to learn more.
